Recombinant anti-TNF-alpha antibodies
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant anti-TNF-alpha antibodies, covering 2019-11-27 to 2019-11-27. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection [Phase 3]